Implications of the initial Braidwood v. Becerra ruling for colorectal cancer outcomes: a modeling study
JNCI: Journal of the National Cancer Institute · 2025
DOI: 10.1093/jnci/djae244 ↗Kurz gefasst
Fachartikel in der Zeitschrift JNCI: Journal of the National Cancer Institute, 2025. Verfasst von Rosita Van Den Puttelaar und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Public Health, Erasmus University Medical Center, 3015GD Rotterdam, The Netherlands. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Early Detection of Cancer, Patient Protection and Affordable Care Act, Cost Sharing. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Cancer Center Support, NCI NIH HHS, NIH HHS.
Abstract (Originalsprache)
The Affordable Care Act (ACA) eliminated patient cost-sharing for United States Preventive Service Task Force (USPSTF) recommended services. However, if the US Court of Appeals for the Fifth Circuit fully upheld a US District Court ruling in Braidwood Management v. Becerra, 666 F. Supp. 3d 613 (N.D. Tex 2023), cost-sharing for USPSTF recommendations made after ACA passage would have been reinstated for more than 150 million people. The case would have reinstated cost-sharing for colorectal cancer (CRC) screening for ages 45-49 years and for polyp removal during (diagnostic) colonoscopy across all ages. Using the MISCAN-Colon model, we simulated the potential impact on CRC outcomes, assuming early-onset CRC trends and lower screening participation. An 8-percentage-point decline in screening participation could increase CRC incidence by 5.1% and CRC mortality by 9.1%, with slightly lower costs due to increased cost-sharing. Larger decreases in screening participation can result in higher costs from increased incidence and delayed diagnoses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Public Health, Erasmus University Medical Center, 3015GD Rotterdam, The Netherlands.
- Surveillance and Health Equity Science Department, American Cancer Society, Atlanta, GA 30303, USA.
- Center for Early Cancer Detection Science, American Cancer Society, Atlanta, GA 30303, USA.
- Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
ORCID-Profile: Rosita Van Den Puttelaar, Jingxuan Zhao, Margaret Katana Ogongo, Anne I Hahn, Ann G Zauber, K Robin Yabroff, Iris Lansdorp-Vogelaar
Förderung
- Cancer Center Support
- NCI NIH HHS
- NIH HHS
- NCI
- American Cancer Society
- Cancer Intervention and Surveillance Modeling Network
- National Cancer Institute
- National Institutes of Health
Zitieren
APA
Van Den Puttelaar, R., Shi, K. S., Smith, R., Zhao, J., Ogongo, M. K., Harlass, M., Hahn, A. I., Zauber, A. G., Yabroff, K. R., & Lansdorp-Vogelaar, I. (2025). Implications of the initial Braidwood v. Becerra ruling for colorectal cancer outcomes: a modeling study. JNCI: Journal of the National Cancer Institute. https://doi.org/10.1093/jnci/djae244
Vancouver
Van Den Puttelaar R, Shi KS, Smith R, Zhao J, Ogongo MK, Harlass M, et al. Implications of the initial Braidwood v. Becerra ruling for colorectal cancer outcomes: a modeling study. JNCI: Journal of the National Cancer Institute. 2025. doi:10.1093/jnci/djae244
BibTeX
@article{VanDenPuttelaar2025,
author = {Van Den Puttelaar, Rosita and Shi, Kewei Sylvia and Smith, Robert and Zhao, Jingxuan and Ogongo, Margaret Katana and Harlass, Matthias and Hahn, Anne I and Zauber, Ann G and Yabroff, K Robin and Lansdorp-Vogelaar, Iris},
title = {Implications of the initial Braidwood v. Becerra ruling for colorectal cancer outcomes: a modeling study},
journal = {JNCI: Journal of the National Cancer Institute},
year = {2025},
doi = {10.1093/jnci/djae244}
}
EUVIMED